Clinical trials
Phase 2/3 Urinary Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 5 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Bioniche Life Sciences Inc. | 1 |
| CG Oncology, Inc. | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Cancer Research UK | 1 |
| Daiichi Sankyo | 1 |
| Dr Anjali Zarkar | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| ImmunityBio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 21 |
| Carcinoma, Transitional Cell | 6 |
| Carcinoma in Situ | 3 |
| Neoplasms | 3 |
| Non-Muscle Invasive Bladder Neoplasms | 3 |
| Lung Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Adenoviridae Infections | 1 |
| Cholangiocarcinoma | 1 |
Trials
Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.